Breaking News Instant updates and real-time market news.

CVS

CVS Health

$52.81 /

+0.09 (+0.17%)

06:13
04/15/19
04/15
06:13
04/15/19
06:13

CVS Health downgraded to Perform from Outperform at Oppenheimer

  • 01

    May

CVS CVS Health
$52.81 /

+0.09 (+0.17%)

04/11/19
Fly Intel: Top five analyst initiations
04/10/19 BMO Capital
CVS Health initiated with a Market Perform at BMO Capital
04/10/19 SunTrust
SunTrust lowers price targets on CVS, raises price target on WellCare
04/10/19 Cantor Fitzgerald
Senate hearing a net positive for PBMs, says Cantor Fitzgerald

TODAY'S FREE FLY STORIES

Hot Stocks
Greenlane partners with NEO Plastics for sustainable packaging » 07:28
07/13/20
07/13
07:28
07/13/20
07:28
GNLN

Greenlane

$3.38 /

+0.2 (+6.29%)

Greenlane Holdings…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNLN Greenlane
$3.38 /

+0.2 (+6.29%)

GNLN Greenlane
$3.38 /

+0.2 (+6.29%)

03/31/20 Roth Capital
Greenlane price target lowered to $4 from $9 at Roth Capital
10/07/19 Roth Capital
Greenlane price target lowered to $10 from $18.50 at Roth Capital
GNLN Greenlane
$3.38 /

+0.2 (+6.29%)

GNLN Greenlane
$3.38 /

+0.2 (+6.29%)

Recommendations
Zymeworks price target raised to $42 from $25 at Canaccord » 07:28
07/13/20
07/13
07:28
07/13/20
07:28
ZYME

Zymeworks

$33.35 /

-1.8 (-5.12%)

Canaccord analyst Arlinda…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ZYME Zymeworks
$33.35 /

-1.8 (-5.12%)

ZYME Zymeworks
$33.35 /

-1.8 (-5.12%)

07/09/20 H.C. Wainwright
Zymeworks 'evasiveness' not what Street wanted, says H.C. Wainwright
03/03/20 H.C. Wainwright
Zymeworks price target lowered to $60 from $65 at H.C. Wainwright
02/02/20 Stifel
Zymeworks price target raised to $70 from $45 at Stifel
01/15/20 Wells Fargo
Zymeworks price target raised to $58 from $48 at Wells Fargo
ZYME Zymeworks
$33.35 /

-1.8 (-5.12%)

  • 23
    Jan
Recommendations
Vivint Solar price target raised to $18 from $12 at KeyBanc » 07:28
07/13/20
07/13
07:28
07/13/20
07:28
VSLR

Vivint Solar

$15.98 /

+0.66 (+4.31%)

, RUN

Sunrun

$28.88 /

+1.06 (+3.81%)

KeyBanc analyst Sophie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VSLR Vivint Solar
$15.98 /

+0.66 (+4.31%)

RUN Sunrun
$28.88 /

+1.06 (+3.81%)

VSLR Vivint Solar
$15.98 /

+0.66 (+4.31%)

06:13 Today KeyBanc
KeyBanc upgrades Sunrun to Overweight on Vivint merger
07/08/20 Roth Capital
Sunrun, Vivint combined entity results in substantial scale, says Roth Capital
07/08/20 Roth Capital
Vivint Solar acquisition by Sunrun could drive costs lower, says Roth Capital
07/08/20 Oppenheimer
Vivint Solar moved to Not Rated at Oppenheimer after acquisition by Sunrun
RUN Sunrun
$28.88 /

+1.06 (+3.81%)

06:13 Today KeyBanc
KeyBanc upgrades Sunrun to Overweight on Vivint merger
04:44 Today KeyBanc
Sunrun upgraded to Overweight from Sector Weight at KeyBanc
07/08/20 Roth Capital
Sunrun, Vivint combined entity results in substantial scale, says Roth Capital
07/08/20 Roth Capital
Vivint Solar acquisition by Sunrun could drive costs lower, says Roth Capital
VSLR Vivint Solar
$15.98 /

+0.66 (+4.31%)

RUN Sunrun
$28.88 /

+1.06 (+3.81%)

VSLR Vivint Solar
$15.98 /

+0.66 (+4.31%)

VSLR Vivint Solar
$15.98 /

+0.66 (+4.31%)

RUN Sunrun
$28.88 /

+1.06 (+3.81%)

VSLR Vivint Solar
$15.98 /

+0.66 (+4.31%)

RUN Sunrun
$28.88 /

+1.06 (+3.81%)

Recommendations
Roku price target raised to $180 from $153 at Benchmark » 07:28
07/13/20
07/13
07:28
07/13/20
07:28
ROKU

Roku

$152.99 /

+3.36 (+2.25%)

, FB

Facebook

$245.01 /

+0.35 (+0.14%)

, PTON

Peloton

$68.55 /

+4.08 (+6.33%)

, KR

Kroger

$33.43 /

+0.68 (+2.08%)

Benchmark analyst Daniel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROKU Roku
$152.99 /

+3.36 (+2.25%)

FB Facebook
$245.01 /

+0.35 (+0.14%)

PTON Peloton
$68.55 /

+4.08 (+6.33%)

KR Kroger
$33.43 /

+0.68 (+2.08%)

ROKU Roku
$152.99 /

+3.36 (+2.25%)

06/11/20 Oppenheimer
Roku price target raised to $140 from $135 at Oppenheimer
06/04/20 Rosenblatt
Roku weakness on new TCL TVs 'well overdone,' says Rosenblatt
06/03/20 Stephens
Roku may be seeing pressure from Best Buy TCL TVs, says Stephens
06/03/20 SunTrust
New TVs at Best Buy present 'modest' new competition for Roku, says Suntrust
FB Facebook
$245.01 /

+0.35 (+0.14%)

06:26 Today Barclays
Facebook price target raised to $275 from $260 at Barclays
07/09/20 Wedbush
Pinterest price target raised to $31 from $26 at Wedbush
07/07/20 BofA
Potential U.S. ban of TikTok could be tailwind to Snap engagement, says BofA
07/01/20 Monness Crespi
Facebook has opportunity to emerge from crisis stronger, says Monness Crespi
PTON Peloton
$68.55 /

+4.08 (+6.33%)

07/08/20 Rosenblatt
Netflix price target raised to $445 from $370 at Rosenblatt
07/06/20 Wedbush
Peloton removed from Best Ideas List at Wedbush
06/30/20 Roth Capital
Roth boosts Peloton target to $66, says buy Mirror acquisition selloff
06/26/20 Needham
Peloton price target raised to $65 from $50 at Needham
KR Kroger
$33.43 /

+0.68 (+2.08%)

06/19/20 Deutsche Bank
Kroger price target raised to $35 from $33 at Deutsche Bank
06/18/20 Wells Fargo
Kroger risk/reward 'compelling' after earnings selloff, says Wells Fargo
06/15/20 UBS
Kroger price target raised to $35 from $33 at UBS
06/11/20 Oppenheimer
Roku price target raised to $140 from $135 at Oppenheimer
ROKU Roku
$152.99 /

+3.36 (+2.25%)

FB Facebook
$245.01 /

+0.35 (+0.14%)

PTON Peloton
$68.55 /

+4.08 (+6.33%)

KR Kroger
$33.43 /

+0.68 (+2.08%)

  • 17
    Mar
  • 26
    Sep
ROKU Roku
$152.99 /

+3.36 (+2.25%)

FB Facebook
$245.01 /

+0.35 (+0.14%)

PTON Peloton
$68.55 /

+4.08 (+6.33%)

KR Kroger
$33.43 /

+0.68 (+2.08%)

ROKU Roku
$152.99 /

+3.36 (+2.25%)

FB Facebook
$245.01 /

+0.35 (+0.14%)

PTON Peloton
$68.55 /

+4.08 (+6.33%)

KR Kroger
$33.43 /

+0.68 (+2.08%)

ROKU Roku
$152.99 /

+3.36 (+2.25%)

FB Facebook
$245.01 /

+0.35 (+0.14%)

PTON Peloton
$68.55 /

+4.08 (+6.33%)

KR Kroger
$33.43 /

+0.68 (+2.08%)

Earnings
Intertape Polymer raises Q2 revenue view $267M from $235M-$250M » 07:27
07/13/20
07/13
07:27
07/13/20
07:27
ITPOF

Intertape Polymer

$0.00 /

+ (+0.00%)

Consensus $242.8M.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ITPOF Intertape Polymer
$0.00 /

+ (+0.00%)

ITPOF Intertape Polymer
$0.00 /

+ (+0.00%)

07/09/20 Scotiabank
Intertape Polymer price target raised to C$17 from C$16.50 at Scotiabank
05/14/20 Scotiabank
Intertape Polymer price target lowered to C$16.50 from C$17 at Scotiabank
05/14/20 TD Securities
Intertape Polymer price target lowered to C$8 from C$8.50 at TD Securities
05/14/20 CIBC
Intertape Polymer price target raised to C$12.50 from C$11 at CIBC
ITPOF Intertape Polymer
$0.00 /

+ (+0.00%)

Downgrade
SBA Communications downgraded to Sector Weight from Overweight at KeyBanc » 07:25
07/13/20
07/13
07:25
07/13/20
07:25
SBAC

SBA Communications

$304.34 /

-3.44 (-1.12%)

KeyBanc analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBAC SBA Communications
$304.34 /

-3.44 (-1.12%)

SBAC SBA Communications
$304.34 /

-3.44 (-1.12%)

06/09/20 JPMorgan
SBA Communications upgraded to Overweight with $335 target at JPMorgan
06/09/20 JPMorgan
SBA Communications upgraded to Overweight from Neutral at JPMorgan
06/05/20 Deutsche Bank
SBA Communications resumed with a Buy at Deutsche Bank
05/06/20 Wells Fargo
SBA Communications price target raised to $325 from $305 at Wells Fargo
SBAC SBA Communications
$304.34 /

-3.44 (-1.12%)

SBAC SBA Communications
$304.34 /

-3.44 (-1.12%)

SBAC SBA Communications
$304.34 /

-3.44 (-1.12%)

Downgrade
American Tower downgraded to Sector Weight from Overweight at KeyBanc » 07:25
07/13/20
07/13
07:25
07/13/20
07:25
AMT

American Tower

$264.42 /

-1.41 (-0.53%)

KeyBanc analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMT American Tower
$264.42 /

-1.41 (-0.53%)

AMT American Tower
$264.42 /

-1.41 (-0.53%)

06/09/20 JPMorgan
SBA Communications upgraded to Overweight with $335 target at JPMorgan
06/05/20 Deutsche Bank
American Tower resumed with a Buy at Deutsche Bank
05/22/20 Oppenheimer
American Tower upgraded to Outperform from Perform at Oppenheimer
05/22/20 Oppenheimer
American Tower upgraded to Outperform from Perform at Oppenheimer
AMT American Tower
$264.42 /

-1.41 (-0.53%)

AMT American Tower
$264.42 /

-1.41 (-0.53%)

AMT American Tower
$264.42 /

-1.41 (-0.53%)

Conference/Events
Mesoblast participates in a conference call with Cantor Fitzgerald » 07:25
07/13/20
07/13
07:25
07/13/20
07:25
MESO

Mesoblast

$13.08 /

+0.025 (+0.19%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MESO Mesoblast
$13.08 /

+0.025 (+0.19%)

MESO Mesoblast
$13.08 /

+0.025 (+0.19%)

06/22/20 Dawson James
Channel checks dispute NY Times' COVID contention, says Dawson James
05/28/20 Ladenburg
Mesoblast price target raised to $15.25 from $13 at Ladenburg
05/28/20 H.C. Wainwright
Mesoblast price target raised to $21 from $14 at H.C. Wainwright
04/09/20 H.C. Wainwright
H.C. Wainwright 'encouraged' by Mesoblast's plan to study Ryoncil in ARDS
MESO Mesoblast
$13.08 /

+0.025 (+0.19%)

MESO Mesoblast
$13.08 /

+0.025 (+0.19%)

Conference/Events
Gritstone Oncology to host conference call » 07:25
07/13/20
07/13
07:25
07/13/20
07:25
GRTS

Gritstone Oncology

$8.15 /

+1.05 (+14.79%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRTS Gritstone Oncology
$8.15 /

+1.05 (+14.79%)

GRTS Gritstone Oncology
$8.15 /

+1.05 (+14.79%)

07/26/19
Fly Intel: Top five analyst initiations
07/25/19 Baird
Gritstone Oncology initiated with an Outperform at Baird
GRTS Gritstone Oncology
$8.15 /

+1.05 (+14.79%)

Recommendations
D.R. Horton price target raised to $66 ahead of earnings at Seaport Global » 07:24
07/13/20
07/13
07:24
07/13/20
07:24
DHI

D.R. Horton

$58.64 /

+0.58 (+1.00%)

Seaport Global analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DHI D.R. Horton
$58.64 /

+0.58 (+1.00%)

DHI D.R. Horton
$58.64 /

+0.58 (+1.00%)

06/15/20 BTIG
D.R. Horton price target raised to $63 from $51 at BTIG
06/15/20 Citi
D.R. Horton price target raised to $69 from $56 at Citi
06/11/20 JPMorgan
PulteGroup upgraded, KB downgraded as JPMorgan adjusts homebuilder ratings
06/11/20 JPMorgan
D.R. Horton downgraded to Neutral from Overweight at JPMorgan
DHI D.R. Horton
$58.64 /

+0.58 (+1.00%)

DHI D.R. Horton
$58.64 /

+0.58 (+1.00%)

DHI D.R. Horton
$58.64 /

+0.58 (+1.00%)

DHI D.R. Horton
$58.64 /

+0.58 (+1.00%)

Hot Stocks
Summit announces publication of Phase 2 analyses of gut microbiome health » 07:23
07/13/20
07/13
07:23
07/13/20
07:23
SMMT

Summit Therapeutics

$3.19 /

-0.02 (-0.62%)

Summit Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMMT Summit Therapeutics
$3.19 /

-0.02 (-0.62%)

SMMT Summit Therapeutics
$3.19 /

-0.02 (-0.62%)

03/19/20 H.C. Wainwright
Summit Therapeutics assumed with a Buy at H.C. Wainwright
Recommendations
Chegg price target raised to $86 from $80 at KeyBanc » 07:23
07/13/20
07/13
07:23
07/13/20
07:23
CHGG

Chegg

$75.02 /

+2.31 (+3.18%)

KeyBanc analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHGG Chegg
$75.02 /

+2.31 (+3.18%)

CHGG Chegg
$75.02 /

+2.31 (+3.18%)

06/30/20 Citi
Chegg downgraded to Neutral from Buy at Citi
06/29/20 KeyBanc
Chegg initiated with an Overweight at KeyBanc
06/23/20 Northland
Chegg price target raised to $75 from $70 at Northland
06/22/20 Jefferies
Chegg price target raised to $80 from $55 at Jefferies
CHGG Chegg
$75.02 /

+2.31 (+3.18%)

CHGG Chegg
$75.02 /

+2.31 (+3.18%)

CHGG Chegg
$75.02 /

+2.31 (+3.18%)

Hot Stocks
Hi-Crush Inc. files for Chapter 11 bankruptcy » 07:23
07/13/20
07/13
07:23
07/13/20
07:23
HCR

Hi-Crush Inc.

$0.16 /

-0.0047 (-2.90%)

Hi-Crush announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCR Hi-Crush Inc.
$0.16 /

-0.0047 (-2.90%)

HCR Hi-Crush Inc.
$0.16 /

-0.0047 (-2.90%)

03/09/20 Evercore ISI
Hi-Crush Inc. downgraded to Underperform from Outperform at Evercore ISI
11/07/19 AltaCorp
Hi-Crush Inc. downgraded to Underperform from Sector Perform at AltaCorp
HCR Hi-Crush Inc.
$0.16 /

-0.0047 (-2.90%)

HCR Hi-Crush Inc.
$0.16 /

-0.0047 (-2.90%)

Hot Stocks
Cyclacel announces publication of peer-reviewed study of fadraciclib » 07:22
07/13/20
07/13
07:22
07/13/20
07:22
CYCC

Cyclacel Pharmaceuticals

$4.46 /

-0.02 (-0.45%)

Cyclacel Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYCC Cyclacel Pharmaceuticals
$4.46 /

-0.02 (-0.45%)

CYCC Cyclacel Pharmaceuticals
$4.46 /

-0.02 (-0.45%)

05/19/20 Brookline
Cyclacel Pharmaceuticals initiated with a Buy at Brookline
04/27/20
Fly Intel: Top five analyst initiations
04/27/20 Roth Capital
Cyclacel Pharmaceuticals assumed with a Buy at Roth Capital
CYCC Cyclacel Pharmaceuticals
$4.46 /

-0.02 (-0.45%)

Downgrade
Lennar downgraded to Neutral following outperformance at Seaport Global » 07:21
07/13/20
07/13
07:21
07/13/20
07:21
LEN

Lennar

$65.27 /

+2 (+3.16%)

, KBH

KB Home

$30.54 /

+1.485 (+5.11%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

07:17 Today Seaport Global
Seaport upgrades KB Home to Buy, sees some current headwinds becoming tailwinds
06:29 Today Seaport Global
Lennar downgraded to Neutral from Buy at Seaport Global
06/18/20 Raymond James
Lennar price target raised to $75 from $41 at Raymond James
06/17/20 RBC Capital
Lennar price target raised to $68 from $61 at RBC Capital
KBH KB Home
$30.54 /

+1.485 (+5.11%)

07:17 Today Seaport Global
Seaport upgrades KB Home to Buy, sees some current headwinds becoming tailwinds
06:35 Today Seaport Global
KB Home upgraded to Buy from Neutral at Seaport Global
06/25/20
Fly Intel: Top five analyst downgrades
06/25/20 Wells Fargo
KB Home price target raised to $33 from $24 at Wells Fargo
LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

Hot Stocks
Ovid Therapeutics, Angelini Pharma enter license agreement for OV101 » 07:21
07/13/20
07/13
07:21
07/13/20
07:21
OVID

Ovid Therapeutics

$7.47 /

-0.32 (-4.11%)

Ovid Therapeutics,and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OVID Ovid Therapeutics
$7.47 /

-0.32 (-4.11%)

OVID Ovid Therapeutics
$7.47 /

-0.32 (-4.11%)

06/18/20 Cantor Fitzgerald
Ovid Therapeutics price target raised to $13 from $7 at Cantor Fitzgerald
05/22/20 Cantor Fitzgerald
Zynerba price target raised to $21 from $12 at Cantor Fitzgerald
05/07/20 Piper Sandler
Ovid's gaboxadol data in Fragile X 'promising,' says Piper Sandler
03/30/20 Piper Sandler
Piper says Ovid data suggests potential use for soticlestat in CDD/Dup15q
OVID Ovid Therapeutics
$7.47 /

-0.32 (-4.11%)

  • 04
    Oct
OVID Ovid Therapeutics
$7.47 /

-0.32 (-4.11%)

Initiation
Teladoc initiated with a Buy at Argus » 07:20
07/13/20
07/13
07:20
07/13/20
07:20
TDOC

Teladoc

$229.30 /

+0.66 (+0.29%)

Argus analyst John Eade…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

07:07 Today Argus
Teladoc initiated with a Buy at Argus
07/06/20 Stephens
Teladoc initiated with an Overweight at Stephens
06/30/20 Piper Sandler
Virtual care market to benefit from PHE extension, says Piper Sandler
06/30/20 Piper Sandler
Piper survey shows over 10 times increase in telemedicine utilization
TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

Hot Stocks
electroCore announces FDA EUA for use of gammaCore Sapphire CV » 07:19
07/13/20
07/13
07:19
07/13/20
07:19
ECOR

electroCore

$0.85 /

-0.004 (-0.47%)

electroCore announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECOR electroCore
$0.85 /

-0.004 (-0.47%)

ECOR electroCore
$0.85 /

-0.004 (-0.47%)

03/10/20 H.C. Wainwright
electroCore initiated with a Buy at H.C. Wainwright
11/14/19 Cantor Fitzgerald
electroCore price target lowered to $4 from $9 at Cantor Fitzgerald
11/14/19 JMP Securities
electroCore downgraded to Market Perform from Outperform at JMP Securities
09/26/19 Cantor Fitzgerald
electroCore assumed with a Neutral at Cantor Fitzgerald
ECOR electroCore
$0.85 /

-0.004 (-0.47%)

Hot Stocks
Altimmune, University of Alabama anounces preclinical results for AdCOVID » 07:18
07/13/20
07/13
07:18
07/13/20
07:18
ALT

Altimmune

$22.32 /

+2.17 (+10.77%)

Altimmune announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALT Altimmune
$22.32 /

+2.17 (+10.77%)

ALT Altimmune
$22.32 /

+2.17 (+10.77%)

06/01/20 Roth Capital
Altimmune surprises with differentiated T-COVID study, says Roth Capital
05/06/20 Roth Capital
Novo data 'sets up the runway' for Altimmune, says Roth Capital
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
ALT Altimmune
$22.32 /

+2.17 (+10.77%)

ALT Altimmune
$22.32 /

+2.17 (+10.77%)

ALT Altimmune
$22.32 /

+2.17 (+10.77%)

Upgrade
Seaport upgrades KB Home to Buy, sees some current headwinds becoming tailwinds » 07:17
07/13/20
07/13
07:17
07/13/20
07:17
KBH

KB Home

$30.54 /

+1.485 (+5.11%)

, LEN

Lennar

$65.27 /

+2 (+3.16%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

06:35 Today Seaport Global
KB Home upgraded to Buy from Neutral at Seaport Global
06/25/20
Fly Intel: Top five analyst downgrades
06/25/20 Wells Fargo
KB Home price target raised to $33 from $24 at Wells Fargo
06/25/20 RBC Capital
KB Home price target lowered to $33 from $34 at RBC Capital
LEN Lennar
$65.27 /

+2 (+3.16%)

06:29 Today Seaport Global
Lennar downgraded to Neutral from Buy at Seaport Global
06/18/20 Raymond James
Lennar price target raised to $75 from $41 at Raymond James
06/17/20 RBC Capital
Lennar price target raised to $68 from $61 at RBC Capital
06/17/20 Wells Fargo
Lennar price target raised to $72 from $67 at Wells Fargo
KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

Periodicals
Toshiba chairman says it has recovered 50% of public trust, Nikkei reports » 07:17
07/13/20
07/13
07:17
07/13/20
07:17
TOSBF

Toshiba, also use TOSYY

$0.00 /

+ (+0.00%)

, TOSYY

Toshiba

$0.00 /

+ (+0.00%)

Toshiba's chairman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TOSBF Toshiba, also use TOSYY
$0.00 /

+ (+0.00%)

TOSYY Toshiba
$0.00 /

+ (+0.00%)

TOSBF Toshiba, also use TOSYY
$0.00 /

+ (+0.00%)

04/22/20 UBS
Toshiba downgraded to Neutral from Buy at UBS
11/27/19 Jefferies
Toshiba upgraded to Buy from Underperform at Jefferies
09/16/19 RBC Capital
Environment sets attractive entry points for Micron, Western, says RBC Capital
07/24/19 Jefferies
Toshiba initiated with an Underperform at Jefferies
TOSYY Toshiba
$0.00 /

+ (+0.00%)

04/22/20 UBS
Toshiba downgraded to Neutral from Buy at UBS
03/19/20 Citi
Toshiba upgraded to Neutral from Sell at Citi
11/27/19 Jefferies
Toshiba upgraded to Buy from Underperform at Jefferies
11/27/19 Jefferies
Toshiba upgraded to Buy from Underperform at Jefferies
TOSBF Toshiba, also use TOSYY
$0.00 /

+ (+0.00%)

TOSYY Toshiba
$0.00 /

+ (+0.00%)

Hot Stocks
EyePoint appoints Jay Duker as chief strategic scientific officer » 07:16
07/13/20
07/13
07:16
07/13/20
07:16
EYPT

EyePoint

$0.75 /

+0.0481 (+6.81%)

EyePoint Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EYPT EyePoint
$0.75 /

+0.0481 (+6.81%)

EYPT EyePoint
$0.75 /

+0.0481 (+6.81%)

04/06/20 B. Riley FBR
EyePoint downgraded to Neutral from Buy at B. Riley FBR
11/11/19 H.C. Wainwright
EyePoint downgraded to Neutral from Buy at H.C. Wainwright
09/11/19 Guggenheim
EyePoint initiated with a Buy at Guggenheim
09/11/19 Guggenheim
EyePoint initiated with a Buy at Guggenheim
EYPT EyePoint
$0.75 /

+0.0481 (+6.81%)

  • 21
    Feb
Hot Stocks
Rocket Pharmaceuticals announces first patient treated in RP-L301 trial » 07:16
07/13/20
07/13
07:16
07/13/20
07:16
RCKT

Rocket Pharmaceuticals

$22.58 /

-1.06 (-4.48%)

Rocket Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCKT Rocket Pharmaceuticals
$22.58 /

-1.06 (-4.48%)

RCKT Rocket Pharmaceuticals
$22.58 /

-1.06 (-4.48%)

07/02/20 JPMorgan
Rocket Pharmaceuticals initiated with an Overweight at JPMorgan
06/25/20 BofA
Rocket Pharmaceuticals reinstated with a Buy at BofA
06/25/20 BofA
Rocket Pharmaceuticals reinstated with a Buy at BofA
05/13/20 Piper Sandler
Rocket Pharmaceuticals programs look even more promising, says Piper Sandler
RCKT Rocket Pharmaceuticals
$22.58 /

-1.06 (-4.48%)

  • 11
    Dec
Hot Stocks
Calithera Biosciences initiates Phase 1b trial of CB-280 » 07:15
07/13/20
07/13
07:15
07/13/20
07:15
CALA

Calithera Biosciences

$5.14 /

-0.1 (-1.91%)

Calithera Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CALA Calithera Biosciences
$5.14 /

-0.1 (-1.91%)

CALA Calithera Biosciences
$5.14 /

-0.1 (-1.91%)

05/11/20 Citi
Calithera Biosciences price target raised to $10 from $7 at Citi
05/08/20 H.C. Wainwright
Calithera Biosciences price target raised to $9.50 from $7 at H.C. Wainwright
03/27/20
Fly Intel: Top five analyst initiations
03/27/20 Jefferies
Jefferies starts Calithera at Buy ahead of three data catalysts
CALA Calithera Biosciences
$5.14 /

-0.1 (-1.91%)

  • 16
    Apr
CALA Calithera Biosciences
$5.14 /

-0.1 (-1.91%)

Hot Stocks
Tonix enters research, license agreement with Kansas State University » 07:14
07/13/20
07/13
07:14
07/13/20
07:14
TNXP

Tonix Pharmaceuticals

$0.64 /

-0.0208 (-3.16%)

Tonix Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TNXP Tonix Pharmaceuticals
$0.64 /

-0.0208 (-3.16%)

TNXP Tonix Pharmaceuticals
$0.64 /

-0.0208 (-3.16%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
TNXP Tonix Pharmaceuticals
$0.64 /

-0.0208 (-3.16%)

  • 16
    Jul
TNXP Tonix Pharmaceuticals
$0.64 /

-0.0208 (-3.16%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.